Not applicableCompletedINTERVENTIONAL
Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
ClinicalTrials.gov · NCT04829903 · Registry updated: 2022-03-14
- Condition / research focus
- Type 2 Diabetes Treated With Insulin; Obesity; Adolescent Obesity
- Sponsor
- Corporacion Parc Tauli
- Countries with listed sites
- Pakistan
- Registry dates and results
- Start: 2020-01-02. Completion: 2021-11-20 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Dulaglutide (drug) — also listed as: Group DUL
- Liraglutide (drug) — also listed as: Group LIR
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Zainab Khan
Lahore, Punjab Province, Pakistan
Site recruitment: Not reported